Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Compounded peptides are not subject to the same manufacturing standards as FDA-approved drugs
Specific findings worth noting: in a rat model of cysteamine-induced duodenal ulcers, BPC-157 administered intraperitoneally at 10 mcg/kg reduced ulcer area by approximately 75% compared to controls within 72 hours 4
Low and elevated KLOW dose adjustments Low Dose: 1.6 mg total contains 1 mg GHK-Cu and 200 mcg each of BPC-157, TB-4, and KPV
Very simple to inject
Maximum benefits usually emerge around the 3-6 month mark
US$ 21.07
US$ 23.73
US$ 21.09
US$ 29.06
US$ 24.98
US$ 22.69
